专科医生确认的COVID-19 mRNA疫苗过敏反应在大规模接种点的前瞻性研究
在Albany社区疫苗接种中心开展前瞻性研究,所有受种者接种前由过敏专科医生筛查过敏史。前14天接种14,655人,其中3.9%有个人过敏反应史,无人出现客观的即时过敏症状。专科医生确认的mRNA新冠疫苗即时过敏反应率远低于主观自报率。
要点
- 接种前由过敏专科医生筛查过敏史可有效识别高风险者。
- 14,655名受种者中3.9%有个人过敏反应史,无人出现客观即时过敏症状。
- 专科医生确认的即时过敏反应率远低于主观自报症状定义的发生率。
核心结论
- 专科医生确认的mRNA SARS-CoV-2疫苗即时过敏反应率远低于基于主观未确认症状的自报率。
研究设计与样本
- 前瞻性研究,在Albany社区疫苗接种中心对所有受种者接种前由委员会认证的过敏专科医生筛查过敏史。
- 前14天共接种14,655人,其中3.9%有个人过敏反应史。
主要发现
- 部分受种者出现非过敏性并发症,但无人出现任何客观的即时过敏症状。
临床怎么用
- 接种前由过敏专科医生筛查过敏史有助于安全推进大规模疫苗接种。
- 应重视文献中疫苗安全性的矛盾数据,以专科确认的过敏反应率为准。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Healthcare providers can play a key role in reaching the target for vaccine uptake through educating the public on the risk may be of severe allergic reactions to COVID-19 vaccines. Thus, it is important to resolve reports in the literature which present conflicting data on vaccine safety. We performed a prospective study of Pfizer-BioNTech vaccinations administered at the Albany Community Vaccination Center. All potential vaccinees to the site were screened for allergic history prior to triage by a board-certified allergist. In the first 14 days of operation, our site vaccinated 14,655 individuals, 3.9% of which had a personal history of anaphylaxis. While some vaccine recipients had non-allergic complications, none of the visitors suffered any objective, immediate allergic symptoms. Our findings indicate that specialist-confirmed rates of immediate allergic reaction to mRNA SARS-CoV-2 vaccination are far lower than self-reported rates defined by subjective, unconfirmed symptoms.
引用
- Myles IA, Vinciguerra JS, Premus RT, et al. Specialist confirmed allergic reactions to COVID-19 mRNA vaccines at a mass vaccination site. Vaccine. 2021. PMID: 34217573. doi:10.1016/j.vaccine.2021.06.061
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。